Table 2 Ocular history and central foveal thickness of patients.

From: Factors predicting final visual outcome in quiescent proliferative diabetic retinopathy

 

N = 118 eyes

BCVA (logMAR, mean ± SD)

0.179 ± 0.199

Time after PRP (y, mean ± SD, range)

7.1 ± 5.4 (1.0–20)

Anti-VEGF injections (mean ± SD, range)

0.6 ± 1.4 (0–9)

Pseudophakia (%)

58 (49.2)

Vitrectomy, n (%)

33 (28.0)

CFT (μm, mean ± SD)

240.9 ± 46.2

  1. BCVA best corrected visual acuity, logMAR logarithm of the minimum angle of resolution, SD standard deviation, PRP panretinal photocoagulation, VEGF vascular endothelial growth factor, CFT central foveal thickness.
Back to article page